Good News
Brainstorm Cell Therapeutics Received Written Agreement From FDA, Under Special Protocol Assessment, On Design For Phase 3B Trial Of NurOwn In Amyotrophic Lateral Sclerosis Expected To Start In 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Lucky2828 : Nope, nothing great. Beware of shark shorting later.
Sean ParkerOP Lucky2828: good News always brings the price down at first. they're doing a web conference at 8am to talk about it.
rocketeer : shorting has begun. calm before the storm
Sean ParkerOP Lucky2828: I know what you mean, though. I'm not discounting that possibility. It's the handwritten approval for me. It just sounds more significant. I've been wrong many times, so we'll see lol
Lucky2828 Sean ParkerOP: Look at CAUD yesterday. Just be cautious. When market is stagnant, shortees is everywhere.